RethinkPeptides

Ocular Peptides

Explore peptide research and guides on ocular peptides.

Lacritin: The Tear Peptide for Dry Eye

Lacritin is the only known prosecretory tear protein. From 2001 discovery to 2023 human trial, the science of this peptide therapy for dry eye disease.

Ocular Peptides

Pegaptanib: The First Anti-VEGF Agent Approved for Eyes

Pegaptanib (Macugen) was the first anti-VEGF and first aptamer drug approved by the FDA in 2004. How it worked, why ranibizumab replaced it, and its legacy.

Ocular Peptides

Peptide Therapies for Macular Degeneration

Peptide therapies for AMD include anti-VEGF peptide eye drops, integrin inhibitors, neuroprotective peptides, and GLP-1 agonists that may reduce AMD risk.